A
A
A
Patient / Consumer
Know more about Medicines Regulation Know more about access to medicines which do not have a Marketing Authorisation Report a Side Effect Biological and Biosimilar Medicinal Products How we monitor the safety of medicines Know more about the Medicines Supply Chain Know more about Use of Medicines Information Leaflets on Medicines Search for your Medicines
Industry
Pharmaceutical Activities and Inspections Product Quality Defects Reporting Scientific Advice Advertising Registering a product Pharmacovigilance Fees
Health Care Professionals
Search Authorised Medicines in Malta Adverse Drug Reaction Reporting How we monitor the safety of medicinal products Safety Information Clinical Trials Product Quality Defects Reporting Medicines supply chain and regulation Advertising
Home / EU 2017

EU 2017

The Maltese Presidency of the Council of the EU and the role of the Medicines Authority

The Medicines Authority will host various European meetings as part of Malta's Presidency.

Maltese Presidency of the Council of the EU

In the first half of 2017, Malta will hold the Presidency of the Council of the European Union. This will involve the organisation and chairing of meetings of different Council formations and their preparatory bodies and mediating discussions in cooperation with the 28 EU Member States and between EU institutions. Malta is part of the 'Trio Presidency' together with the Netherlands and Slovakia and Malta will take over this role as Presidency from its predecessor Slovakia. The Trio Presidencies determine the long-term objectives and the strategic themes to be tackled over a period of 18 months in order to drive forward the Council's legislative agenda and ensure continuity of the Council business.

The European network

The Medicines Authority is part of the European network of Medicines Regulatory Authorities. On the one hand, this means working together with the European Medicines Agency (EMA) and its scientific committees. On the other hand, the directors of the medicines authorities from all EU Member States meet in the HMA (Heads of Medicines Agencies) and the affiliated working parties. The scientific committees of the EMA, which cover all aspects of medicines evaluation and pharmacovigilance, have their own regular meeting structure and agendas.

In addition to the regular meetings held in London, meetings are also organised in the country that holds the Presidency of the Council of the EU. These so-called "strategic review and learning meetings" are organised by the medicines agency of that country. HMA meetings always take place in the country that holds the EU presidency and the medicines agency of the hosting country is influential in determining the agenda with discussions that affect all the national agencies.